Joseph T. Repine
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Nitric Oxide and Endothelin Effects, Chemical Synthesis and Analysis, Fluorine in Organic Chemistry, Renin-Angiotensin System Studies
Most-Cited Works
- → Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6(2005)501 cited
- → Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4(2005)149 cited
- → Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites(1990)74 cited
- → Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists(1997)46 cited
- → Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents(1986)35 cited
- → Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder(2011)27 cited
- → Butenolide Endothelin Antagonists with Improved Aqueous Solubility(1999)24 cited
- → New inhibitors of human renin that contain novel replacements at the P2 site(1991)24 cited
- → Renin inhibitors containing .alpha.-heteroatom amino acids as P2 residues(1992)23 cited
- → Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate(1991)20 cited